0.320 CD

- (-%)

Range 0.320 - 0.320   (-%)
Open 0.320
Previous Close 0.320
Buy Price 0.310
Buy Volume 20.9
Sell Price 0.320
Sell Volume 15
Volume 35
Value 11,200
Remark CD
Measurement Type Value
EPS (SGD) 0.025
Trailing EPS (SGD) 0.025
NAV (SGD) 0.508
Cash In Hand (SGD) 0.058
Dividend 0.01
Dividend Yield (%) 3.125
PE 12.559
Trailing PE 12.561
Price / NAV 0.629
Price / Cash In Hand 5.498
Issued & Paid-up Shares 254,007,000
Treasury Shares 13,518,000
Market Cap (M) 81.282
Par Value (SGD) n.a.
Beta - 75 Days 1.047
R-Squared - 75 Days(%) 19.69
Beta - 500 Days 0.91
R-Squared - 500 Days(%) 6.28
ISIN Code SG2E64980112
Under CPF Investment Scheme (CPFIS) Yes
Index Components FTSE ST Fledgling
Delayed prices. Updated at 08 Apr 2020 15:38.
Data powered by

Upcoming Events


Ex-Date: 06 May 2020
Record Date: 08 May 2020
Payable Date: 22 May 2020
Rate: SGD 0.01 Per Security
Data powered by SGX.
View All Events

About Cordlife

Cordlife Group Limited is an investment holding company engaged in the provision of cord blood banking services, which involves the processing and storage of stem cells. The Company operates as a consumer healthcare company. Its segments include Banking, Diagnostic and Others. The banking segment comprises cord blood and cord lining services. The diagnostics segment comprises Metascreen, which is a metabolic screening test specially designed for newborn babies, non-invasive prenatal testing service, and Eyescreen, a noninvasive pediatric eye-screening service. The cord blood and cord lining are collected, processed and stored in the various laboratories in the regions that the Company operates in. The Company also releases cord blood units for transplants, and for the treatment of cerebral palsy, as well as for other therapeutic uses. It has processing and cryopreservation storage facilities across Asia, namely in Singapore, Hong Kong, India, Indonesia, Malaysia and the Philippines.

Loading Chart...

Target Price
Add Stop Loss
Time Frames
Share With: